![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Alberta Health Services (AHS) (1)
02 BC CANCER, PART OF THE PROVINCIAL HEALTH SERVICES AUTHORITY (1)
03 CIUSS DE L'ESTRIE - CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE (1)
04 Isologic Innovative Radiopharmaceuticals (1)
05 LAWSON HEALTH RESEARCH INSTITUTE (1)
06 NOVA SCOTIA HEALTH AUTHORITY (1)
07 SYLVIA FEDORUK CANADIAN CENTRE FOR NUCLEAR INNOVATION (1)
08 THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE (1)
09 WINNIPEG REGIONAL HEALTH AUTHORITY (1)
01 FLUDEOXYGLUCOSE 18F (9)
01 SOLUTION (9)
01 18F-FLUDEOXYGLUCOSE (18F-FDG) (1)
02 ATLANTISCAN (1)
03 CYCLODX (1)
04 FLUDEOXYGLUCOSE (18F) INJECTION (2)
05 FLUDEOXYGLUCOSE (F-18) (1)
06 FLUDEOXYGLUCOSE [F-18] FDG INJECTION (1)
07 FLUGLUCOSCAN INJECTION (1)
08 [F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION (1)